A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001

Clinical trial NCT02334423 · COMPLETED

Trial details

NCT number: NCT02334423
Sponsor: Evolus, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Glabellar Frown Lines

Start date: 2015-01-01
Primary completion: 2015-12-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.